Expression of ST3GAL4 Leads to SLex Expression and Induces c-Met Activation and an Invasive Phenotype in Gastric Carcinoma Cells

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Gomes, Catarina ^a   Osório, Hugo ^a,c   Pinto, Marta Teixeira ^a   Campos, Diana ^a   Oliveira, Maria José ^b,c   Reis, Celso A ^a,c  

^a UNIVERSITY OF PORTO   (Portugal)

^b INEB INSTITUTO DE ENGENHARIA BIOMÉDICA   (Portugal)

^c University of Porto   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

FOCAL ADHESION KINASE; PROTEIN CDC42; PROTEIN ST3GAL3; PROTEIN ST3GAL4; PROTEIN TYROSINE KINASE; RAC1 PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SCATTER FACTOR RECEPTOR; SIALYL LEWIS X ANTIGEN; SIALYLTRANSFERASE; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CARCINOMA CELL; CELL ADHESION; CELL PROLIFERATION; CHORIOALLANTOIS; CONTROLLED STUDY; DISEASE ASSOCIATION; EMBRYO; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME SYNTHESIS; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PHENOTYPE; PROTEIN TARGETING; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; TUMOR INVASION;

ANIMALS; ANTIGENS, CD15; CELL ADHESION; CELL LINE, TUMOR; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; ENZYME ACTIVATION; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INDOLES; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; OLIGOSACCHARIDES; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-MET; PYRIMIDINES; SIALYLTRANSFERASES; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; STOMACH NEOPLASMS; SULFONES;

EID: 84879165131     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066737     Document Type: Article

References (66)

1. Reis CA, Osorio H, Silva L, Gomes C, David L, (2010) Alterations in glycosylation as biomarkers for cancer detection. J Clin Pathol 63: 322-329.
2. Fuster MM, Esko JD, (2005) The sweet and sour of cancer: glycans as novel therapeutic targets. Nat Rev Cancer 5: 526-542.
3. Varki A, (1994) Selectin ligands. Proc Natl Acad Sci U S A 91: 7390-7397.
4. Borsig L, Wong R, Hynes RO, Varki NM, Varki A, (2002) Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis. Proc Natl Acad Sci U S A 99: 2193-2198.
5. Fukuoka K, Narita N, Saijo N, (1998) Increased expression of sialyl Lewis(x) antigen is associated with distant metastasis in lung cancer patients: immunohistochemical study on bronchofiberscopic biopsy specimens. Lung Cancer 20: 109-116.
6. Kim YJ, Borsig L, Varki NM, Varki A, (1998) P-selectin deficiency attenuates tumor growth and metastasis. Proc Natl Acad Sci U S A 95: 9325-9330.
7. Tatsumi M, Watanabe A, Sawada H, Yamada Y, Shino Y, et al. (1998) Immunohistochemical expression of the sialyl Lewis x antigen on gastric cancer cells correlates with the presence of liver metastasis. Clin Exp Metastasis 16: 743-750.
8. Amado M, Carneiro F, Seixas M, Clausen H, Sobrinho-Simoes M, (1998) Dimeric sialyl-Le(x) expression in gastric carcinoma correlates with venous invasion and poor outcome. Gastroenterology 114: 462-470.
9. Baldus SE, Zirbes TK, Monig SP, Engel S, Monaca E, et al. (1998) Histopathological subtypes and prognosis of gastric cancer are correlated with the expression of mucin-associated sialylated antigens: Sialosyl-Lewis(a), Sialosyl-Lewis(x) and sialosyl-Tn. Tumour Biol 19: 445-453.
10. Grabowski P, Mann B, Mansmann U, Lovin N, Foss HD, et al. (2000) Expression of SIALYL-Le(x) antigen defined by MAb AM-3 is an independent prognostic marker in colorectal carcinoma patients. Int J Cancer 88: 281-286.
11. Nakamori S, Kameyama M, Imaoka S, Furukawa H, Ishikawa O, et al. (1997) Involvement of carbohydrate antigen sialyl Lewis(x) in colorectal cancer metastasis. Dis Colon Rectum 40: 420-431.
12. Nakamori S, Nishihara S, Ikehara Y, Nagano H, Dono K, et al. (1999) Molecular mechanism involved in increased expression of sialyl Lewis antigens in ductal carcinoma of the pancreas. J Exp Clin Cancer Res 18: 425-432.
13. Harduin-Lepers A, Krzewinski-Recchi MA, Colomb F, Foulquier F, Groux-Degroote S, et al. (2012) Sialyltransferases functions in cancers. Front Biosci (Elite Ed) 4: 499-515.
14. Harduin-Lepers A, Mollicone R, Delannoy P, Oriol R, (2005) The animal sialyltransferases and sialyltransferase-related genes: a phylogenetic approach. Glycobiology 15: 805-817.
15. Harduin-Lepers A, Vallejo-Ruiz V, Krzewinski-Recchi MA, Samyn-Petit B, Julien S, et al. (2001) The human sialyltransferase family. Biochimie 83: 727-737.
16. Kono M, Ohyama Y, Lee YC, Hamamoto T, Kojima N, et al. (1997) Mouse beta-galactoside alpha 2,3-sialyltransferases: comparison of in vitro substrate specificities and tissue specific expression. Glycobiology 7: 469-479.
17. Okajima T, Fukumoto S, Miyazaki H, Ishida H, Kiso M, et al. (1999) Molecular cloning of a novel alpha2,3-sialyltransferase (ST3Gal VI) that sialylates type II lactosamine structures on glycoproteins and glycolipids. J Biol Chem 274: 11479-11486.
18. Ellies LG, Sperandio M, Underhill GH, Yousif J, Smith M, et al. (2002) Sialyltransferase specificity in selectin ligand formation. Blood 100: 3618-3625.
19. Sperandio M, Frommhold D, Babushkina I, Ellies LG, Olson TS, et al. (2006) Alpha 2,3-sialyltransferase-IV is essential for L-selectin ligand function in inflammation. Eur J Immunol 36: 3207-3215.
20. Kitagawa H, Paulson JC, (1993) Cloning and expression of human Gal beta 1,3(4)GlcNAc alpha 2,3-sialyltransferase. Biochem Biophys Res Commun 194: 375-382.
21. Colomb F, Krzewinski-Recchi MA, El Machhour F, Mensier E, Jaillard S, et al. (2012) TNF regulates sialyl-Lewisx and 6-sulfo-sialyl-Lewisx expression in human lung through up-regulation of ST3GAL4 transcript isoform BX. Biochimie 94: 2045-2053.
22. Carvalho AS, Harduin-Lepers A, Magalhaes A, Machado E, Mendes N, et al. (2010) Differential expression of alpha-2,3-sialyltransferases and alpha-1,3/4-fucosyltransferases regulates the levels of sialyl Lewis a and sialyl Lewis x in gastrointestinal carcinoma cells. Int J Biochem Cell Biol 42: 80-89.
23. Jun L, Yuanshu W, Yanying X, Zhongfa X, Jian Y, et al. (2012) Altered mRNA expressions of sialyltransferases in human gastric cancer tissues. Med Oncol 29: 84-90.
24. Petretti T, Schulze B, Schlag PM, Kemmner W, (1999) Altered mRNA expression of glycosyltransferases in human gastric carcinomas. Biochim Biophys Acta 1428: 209-218.
25. Cazet A, Bobowski M, Rombouts Y, Lefebvre J, Steenackers A, et al. (2012) The ganglioside G(D2) induces the constitutive activation of c-Met in MDA-MB-231 breast cancer cells expressing the G(D3) synthase. Glycobiology 22: 806-816.
26. Cazet A, Groux-Degroote S, Teylaert B, Kwon KM, Lehoux S, et al. (2009) GD3 synthase overexpression enhances proliferation and migration of MDA-MB-231 breast cancer cells. Biol Chem 390: 601-609.
27. Cazet A, Julien S, Bobowski M, Krzewinski-Recchi MA, Harduin-Lepers A, et al. (2010) Consequences of the expression of sialylated antigens in breast cancer. Carbohydr Res 345: 1377-1383.
28. Organ SL, Tsao MS, (2011) An overview of the c-MET signaling pathway. Ther Adv Med Oncol 3: S7-S19.
29. Liu X, Newton RC, Scherle PA, (2010) Developing c-MET pathway inhibitors for cancer therapy: progress and challenges. Trends Mol Med 16: 37-45.
30. Drake PM, Cho W, Li B, Prakobphol A, Johansen E, et al. (2010) Sweetening the pot: adding glycosylation to the biomarker discovery equation. Clin Chem 56: 223-236.
31. Hakomori S, (2002) Glycosylation defining cancer malignancy: new wine in an old bottle. Proc Natl Acad Sci U S A 99: 10231-10233.
32. Dube DH, Bertozzi CR, (2005) Glycans in cancer and inflammation--potential for therapeutics and diagnostics. Nat Rev Drug Discov 4: 477-488.
33. Varki A, (2008) Sialic acids in human health and disease. Trends Mol Med 14: 351-360.
34. Kannagi R, (1997) Carbohydrate-mediated cell adhesion involved in hematogenous metastasis of cancer. Glycoconj J 14: 577-584.
35. Takada A, Ohmori K, Yoneda T, Tsuyuoka K, Hasegawa A, et al. (1993) Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. Cancer Res 53: 354-361.
36. Kannagi R, Izawa M, Koike T, Miyazaki K, Kimura N, (2004) Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesis. Cancer Sci 95: 377-384.
37. Ichikawa D, Kitamura K, Tani N, Nishida S, Tsurutome H, et al. (2000) Molecular detection of disseminated cancer cells in the peripheral blood and expression of sialylated antigens in colon cancers. J Surg Oncol 75: 98-102.
38. Nakamori S, Kameyama M, Imaoka S, Furukawa H, Ishikawa O, et al. (1993) Increased expression of sialyl Lewisx antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study. Cancer Res 53: 3632-3637.
39. Aubert M, Panicot L, Crotte C, Gibier P, Lombardo D, et al. (2000) Restoration of alpha(1,2) fucosyltransferase activity decreases adhesive and metastatic properties of human pancreatic cancer cells. Cancer Res 60: 1449-1456.
40. Seales EC, Jurado GA, Brunson BA, Wakefield JK, Frost AR, et al. (2005) Hypersialylation of beta1 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by up-regulating cell motility. Cancer Res 65: 4645-4652.
41. Seales EC, Shaikh FM, Woodard-Grice AV, Aggarwal P, McBrayer AC, et al. (2005) A protein kinase C/Ras/ERK signaling pathway activates myeloid fibronectin receptors by altering beta1 integrin sialylation. J Biol Chem 280: 37610-37615.
42. St Hill CA, Krieser K, Farooqui M, (2011) Neutrophil interactions with sialyl Lewis X on human nonsmall cell lung carcinoma cells regulate invasive behavior. Cancer 117: 4493-4505.
43. Singh R, Subramanian S, Rhodes JM, Campbell BJ, (2006) Peanut lectin stimulates proliferation of colon cancer cells by interaction with glycosylated CD44v6 isoforms and consequential activation of c-Met and MAPK: functional implications for disease-associated glycosylation changes. Glycobiology 16: 594-601.
44. Smolen GA, Sordella R, Muir B, Mohapatra G, Barmettler A, et al. (2006) Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752. Proc Natl Acad Sci U S A 103: 2316-2321.
45. Sierra JR, Tsao MS, (2011) c-MET as a potential therapeutic target and biomarker in cancer. Ther Adv Med Oncol 3: S21-35.
46. Soman NR, Correa P, Ruiz BA, Wogan GN, (1991) The TPR-MET oncogenic rearrangement is present and expressed in human gastric carcinoma and precursor lesions. Proc Natl Acad Sci U S A 88: 4892-4896.
47. Yu J, Miehlke S, Ebert MP, Hoffmann J, Breidert M, et al. (2000) Frequency of TPR-MET rearrangement in patients with gastric carcinoma and in first-degree relatives. Cancer 88: 1801-1806.
48. Lee J, Seo JW, Jun HJ, Ki CS, Park SH, et al. (2011) Impact of MET amplification on gastric cancer: possible roles as a novel prognostic marker and a potential therapeutic target. Oncol Rep 25: 1517-1524.
49. Dua R, Zhang J, Parry G, Penuel E, (2011) Detection of hepatocyte growth factor (HGF) ligand-c-MET receptor activation in formalin-fixed paraffin embedded specimens by a novel proximity assay. PLoS One 6: e15932.
50. Inoue T, Kataoka H, Goto K, Nagaike K, Igami K, et al. (2004) Activation of c-Met (hepatocyte growth factor receptor) in human gastric cancer tissue. Cancer Sci 95: 803-808.
51. Lim SK, Choi YW, Lim IK, Park TJ (2012) BTG2 suppresses cancer cell migration through inhibition of Src-FAK signaling by downregulation of reactive oxygen species generation in mitochondria. Clin Exp Metastasis.
52. Peng L, Ran YL, Hu H, Yu L, Liu Q, et al. (2009) Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src/FAK pathway. Carcinogenesis 30: 1660-1669.
53. Sanchez-Bailon MP, Calcabrini A, Gomez-Dominguez D, Morte B, Martin-Forero E, et al. (2012) Src kinases catalytic activity regulates proliferation, migration and invasiveness of MDA-MB-231 breast cancer cells. Cell Signal 24: 1276-1286.
54. Shen J, Xu L, Owonikoko TK, Sun SY, Khuri FR, et al. (2012) NNK promotes migration and invasion of lung cancer cells through activation of c-Src/PKCiota/FAK loop. Cancer Lett 318: 106-113.
55. Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF, (2003) Met, metastasis, motility and more. Nat Rev Mol Cell Biol 4: 915-925.
56. de Curtis I, Meldolesi J (2012) Cell surface dynamics- how Rho GTPases orchestrate the interplay between the plasma membrane and the cortical cytoskeleton. J Cell Sci.
57. Machesky LM, Insall RH, (1999) Signaling to actin dynamics. J Cell Biol 146: 267-272.
58. Tapon N, Hall A, (1997) Rho, Rac and Cdc42 GTPases regulate the organization of the actin cytoskeleton. Curr Opin Cell Biol 9: 86-92.
59. Hall A, (1999) Signal transduction pathways regulated by the Rho family of small GTPases. Br J Cancer 80Suppl 1: 25-27.
60. Kjoller L, Hall A, (1999) Signaling to Rho GTPases. Exp Cell Res 253: 166-179.
61. Pertz O, (2010) Spatio-temporal Rho GTPase signaling- where are we now? J Cell Sci 123: 1841-1850.
62. Evers EE, Zondag GC, Malliri A, Price LS, ten Klooster JP, et al. (2000) Rho family proteins in cell adhesion and cell migration. Eur J Cancer 36: 1269-1274.
63. Parri M, Chiarugi P, (2010) Rac and Rho GTPases in cancer cell motility control. Cell Commun Signal 8: 23.
64. Wessler S, Gimona M, Rieder G, (2011) Regulation of the actin cytoskeleton in Helicobacter pylori-induced migration and invasive growth of gastric epithelial cells. Cell Commun Signal 9: 27.
65. Kamai T, Yamanishi T, Shirataki H, Takagi K, Asami H, et al. (2004) Overexpression of RhoA, Rac1, and Cdc42 GTPases is associated with progression in testicular cancer. Clin Cancer Res 10: 4799-4805.
66. Leve F, Marcondes TG, Bastos LG, Rabello SV, Tanaka MN, et al. (2011) Lysophosphatidic acid induces a migratory phenotype through a crosstalk between RhoA-Rock and Src-FAK signalling in colon cancer cells. Eur J Pharmacol 671: 7-17.